trending Market Intelligence /marketintelligence/en/news-insights/trending/aLPPFcfFagPPf0sCXIxdfg2 content esgSubNav
In This List

InMed Pharmaceuticals names CFO

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


InMed Pharmaceuticals names CFO

InMed Pharmaceuticals Inc. appointed Jeff Charpentier as CFO and corporate secretary.

Charpentier replaces outgoing CFO Terese Gieselman. He has previously served as CFO for Lifebank Corp., Inex Pharmaceuticals Corp. and Chromos Molecular Systems Inc.